Management of Hot Flashes in Women with Breast Cancer
Supportive Care, London Regional Cancer Program, London, ON N6A 4L6, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2010, 17(1), 81-86; https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i1.473
Submission received: 7 November 2009
/
Revised: 11 December 2009
/
Accepted: 5 January 2010
/
Published: 1 February 2010
Abstract
Hormone-suppression therapies are used for the treatment of breast cancer in the adjuvant and metastatic settings alike. However, side effects—including hot flashes—are frequently reported by patients as a cause of therapy discontinuation. This paper presents an overview of hormonal therapies and the evidence-based management options for hot flashes, summarized in a treatment algorithm.
Keywords:
breast cancer; hot flashes; tamoxifen; aromatase inhibitors
Share and Cite
MDPI and ACS Style
Kligman, L.; Younus, J. Management of Hot Flashes in Women with Breast Cancer. Curr. Oncol. 2010, 17, 81-86. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i1.473
AMA Style
Kligman L, Younus J. Management of Hot Flashes in Women with Breast Cancer. Current Oncology. 2010; 17(1):81-86. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i1.473
Chicago/Turabian StyleKligman, L., and J. Younus. 2010. "Management of Hot Flashes in Women with Breast Cancer" Current Oncology 17, no. 1: 81-86. https://0-doi-org.brum.beds.ac.uk/10.3747/co.v17i1.473
